News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
395,150 Results
Type
Article (26383)
Company Profile (60)
Press Release (368705)
Multimedia
Podcasts (37)
Webinars (7)
Section
Business (104806)
Career Advice (455)
Deals (16953)
Drug Delivery (53)
Drug Development (47866)
Employer Resources (47)
FDA (12365)
Job Trends (8496)
News (186976)
Policy (19566)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1761)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26888)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12698)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6900)
BIOSECURE Act (5)
Biosimilars (75)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3059)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (364)
Cervical cancer (26)
Clinical research (43043)
Collaboration (851)
Compensation (275)
Complete response letters (17)
COVID-19 (1555)
CRISPR (35)
C-suite (486)
Cystic fibrosis (59)
Data (4227)
Decentralized trials (2)
Denatured (20)
Depression (94)
Diabetes (316)
Diagnostics (3717)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (124)
Earnings (38798)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54450)
Executive appointments (585)
FDA (14645)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (750)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (543)
Government (3144)
Grass and pollen (4)
Guidances (229)
Healthcare (12253)
HIV (38)
Huntington's disease (20)
IgA nephropathy (52)
Immunology and inflammation (83)
Immuno-oncology (25)
Indications (67)
Infectious disease (1686)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7110)
IRA (23)
Job creations (1850)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (195)
Leadership (8)
Legal (3661)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (291)
MASH (105)
Medical device (13310)
Medtech (13355)
Mergers & acquisitions (10355)
Metabolic disorders (752)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (162)
Neuropsychiatric disorders (42)
Neuroscience (1693)
NextGen: Class of 2026 (3968)
Non-profit (2838)
Now hiring (33)
Obesity (311)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (349)
Peanut (42)
People (35776)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12367)
Phase 2 (18633)
Phase 3 (15288)
Pipeline (3025)
Policy (127)
Postmarket research (1671)
Preclinical (3816)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (178)
Rare diseases (427)
Real estate (2878)
Recruiting (18)
Regulatory (15714)
Reports (18)
Research institute (1654)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (114)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (105)
Sponsored (16)
Startups (2138)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (17)
Vaccines (503)
Venture capital (27)
Weight loss (210)
Women's health (54)
Worklife (4)
Date
Last 7 days (303)
Last 30 days (1063)
Last 365 days (16154)
2026 (1477)
2025 (16497)
2024 (19891)
2023 (22800)
2022 (30855)
2021 (33066)
2020 (32296)
2019 (28476)
2018 (21886)
2017 (18993)
2016 (18218)
2015 (21292)
2014 (16097)
2013 (13280)
2012 (14395)
2011 (14689)
2010 (13228)
Location
Africa (370)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25585)
Australia (4033)
California (5583)
Canada (1904)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (50044)
Florida (950)
Georgia (226)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3734)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1922)
New Mexico (10)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2658)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1351)
Puerto Rico (11)
Rhode Island (35)
South America (525)
South Carolina (59)
Southern California (2235)
Tennessee (124)
Texas (1018)
United States (21617)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (385)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
395,150 Results for "bk medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
August 5, 2025
·
4 min read
Ortho Development® Announces Launch of the BKS® Uni Partial Knee System
Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced the launch of BKS® Uni, the latest addition to its portfolio of Balanced Knee® implant systems.
October 31, 2023
·
1 min read
Press Releases
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
March 11, 2025
·
2 min read
Press Releases
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
December 10, 2024
·
3 min read
Press Releases
Memo Therapeutics AG Announces Last Patient Enrolled in Phase II Clinical Trial of Potravitug for Treatment of BK Viremia in Kidney Transplant Patients
November 4, 2024
·
2 min read
Press Releases
AiCuris Initiates First-in-Human Phase 1 Trial With Antiviral Agent AIC468 to Address BK Virus Infections in Kidney Transplant Recipients
October 31, 2024
·
2 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Deals
GE Healthcare Completes Acquisition of BK Medical
GE announced that it has completed its previously announced acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC.
December 21, 2021
·
4 min read
Press Releases
Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes
January 9, 2026
·
3 min read
Press Releases
BK Virus Infection Market Size to Reach USD 1,274.2 Million by 2034, Impelled by Adoptive T-Cell Therapy
August 2, 2024
·
10 min read
1 of 39,515
Next
